B7-H3-CAR T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for B7-H3-CAR T cells, covering 2026-02-09 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma [Phase 2]